No Data
No Data
No Data
No Data
No Data
Express News | Zhifei Biotech: 26-valent pneumococcal conjugate vaccine obtained clinical trial approval notice
BreakingsApr 29 20:47
Zhifei Biotech (300122): HPV vaccine continuous release development pipeline enters harvest period
The company released the 2023 annual report and the 2024 quarterly report: in 2023, the company achieved revenue of $52,918 billion (+38.30%, the following are all year-on-year ratios) and net profit to mother of 8.070 billion yuan (+7.04
廣發證券Apr 29 18:46
Zhifei Biotech (300122): Further release of the HPV vaccine, and the shingles vaccine will soon contribute new doses
Matters: (1) The company released its 2023 annual report, achieving full year revenue of 52,918 billion yuan (+38.30%) and net profit to mother of 8.070 billion yuan (+7.04%). Net profit after deducting non-return to mother was 7
平安證券Apr 28 20:51
Express News | The latest 10 billion private equity positions revealed! Deng Xiaofeng and Feng Liu move frequently
BreakingsApr 28 08:03
Zhifei Biotech (300122): Changes in agent product structure expected to release shingles vaccine
Incident: The company released the 2023 report and the 2024 quarterly report. In 2023, the company achieved revenue of 52.92 billion yuan, an increase of 38.3% over the previous year; realized net profit to mother of 8.07 billion yuan, an increase of 7% over the previous year; achieved deductions
西南證券Apr 27 00:00
Express News | Zhifei Biotech's affiliate simeglutide declared clinical weight loss indications
BreakingsApr 26 13:10
No Data
No Data